Invesco Ltd. Becton Dickinson & CO Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Invesco Ltd. holds 3,560,774 shares of BDX stock, worth $615 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

3,560,774

Previous 4,265,638 16.52%

Holding current value

$615 Million

Previous $968 Million 15.72%

% of portfolio

0.16%

Previous 0.19%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$222.79 - $249.08 $157 Million - $176 Million	-704,864 Reduced 16.52%	3,560,774 $816 Million
Q4 2024 Feb 13, 2025	BUY	$220.02 - $243.75 $58.8 Million - $65.2 Million	267,436 Added 6.69%	4,265,638 $968 Million
Q3 2024 Nov 12, 2024	BUY	$221.47 - $242.41 $56.2 Million - $61.6 Million	253,930 Added 6.78%	3,998,202 $964 Million
Q2 2024 Aug 13, 2024	SELL	$225.07 - $246.17 $53.6 Million - $58.6 Million	-237,993 Reduced 5.98%	3,744,272 $875 Million
Q1 2024 May 14, 2024	BUY	$233.45 - $247.73 $52.4 Million - $55.6 Million	224,630 Added 5.98%	3,982,265 $985 Million
Q4 2023 Feb 12, 2024	BUY	$232.24 - $267.23 $64.6 Million - $74.4 Million	278,363 Added 8.0%	3,757,635 $916 Million
Q3 2023 Nov 13, 2023	SELL	$254.9 - $283.59 $121 Million - $134 Million	-472,902 Reduced 11.97%	3,479,272 $899 Million
Q2 2023 Aug 11, 2023	BUY	$238.39 - $265.32 $12.4 Million - $13.8 Million	52,020 Added 1.33%	3,952,174 $1.04 Billion
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $41.2 Million - $46.5 Million	179,349 Added 4.82%	3,900,154 $965 Million
Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $10.9 Million - $12.9 Million	50,019 Added 1.36%	3,720,805 $946 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $1.15 Million - $5.96 Million	22,574 Added 0.62%	3,670,786 $818 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $23.7 Million - $27.9 Million	101,153 Added 2.85%	3,648,212 $899 Million
Q1 2022 May 16, 2022	BUY	$243.64 - $270.48 $115 Million - $128 Million	471,726 Added 15.34%	3,547,059 $944 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $116 Million - $127 Million	504,932 Added 19.64%	3,075,333 $773 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $230 Million - $253 Million	986,940 Added 62.33%	2,570,401 $632 Million
Q2 2021 Aug 17, 2021	BUY	$232.65 - $254.58 $7.92 Million - $8.67 Million	34,048 Added 2.2%	1,583,461 $385 Million
Q1 2021 May 17, 2021	SELL	$232.09 - $256.88 $5.95 Million - $6.59 Million	-25,647 Reduced 1.63%	1,549,413 $377 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $36.8 Million - $40.8 Million	165,883 Added 11.77%	1,575,060 $394 Million
Q3 2020 Nov 16, 2020	SELL	$215.77 - $276.76 $7.9 Million - $10.1 Million	-36,611 Reduced 2.53%	1,409,177 $328 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $61.6 Million - $73.7 Million	279,950 Added 24.01%	1,445,788 $346 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $23.4 Million - $33.4 Million	-119,657 Reduced 9.31%	1,165,838 $268 Million
Q4 2019 Feb 14, 2020	SELL	$236.45 - $266.82 $8.68 Million - $9.8 Million	-36,713 Reduced 2.78%	1,285,495 $350 Million
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $12.3 Million - $13.6 Million	-53,234 Reduced 3.87%	1,322,208 $334 Million
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $64.3 Million - $72.7 Million	-295,633 Reduced 17.69%	1,375,442 $347 Million
Q1 2019 May 15, 2019	BUY	$206.05 - $248.17 $68.6 Million - $82.7 Million	333,160 Added 24.9%	1,671,075 $417 Million
Q4 2018 Feb 14, 2019	BUY	$204.73 - $257.93 $274 Million - $345 Million	1,337,915 New	1,337,915 $301 Million

Others Institutions Holding BDX

# of Institutions

1,806

Shares Held

257M

Call Options Held

3.24M

Put Options Held

841K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $49.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account